| 1 |
Downregulation of ATP1A1 promotes cancer development in renal cell carcinoma.Clin Proteomics. 2017 May 4;14:15. doi: 10.1186/s12014-017-9150-4. eCollection 2017.
|
| 2 |
Axl Inhibitor R428 Enhances TRAIL-Mediated Apoptosis Through Downregulation of c-FLIP and Survivin Expression in Renal Carcinoma.Int J Mol Sci. 2019 Jul 2;20(13):3253. doi: 10.3390/ijms20133253.
|
| 3 |
Growth suppression induced by the TRC8 hereditary kidney cancer gene is dependent upon JAB1/CSN5.Oncogene. 2005 May 12;24(21):3503-11. doi: 10.1038/sj.onc.1208509.
|
| 4 |
Up-regulation of 5-lipoxygenase by inhibition of cathepsin G enhances TRAIL-induced apoptosis through down-regulation of survivin.Oncotarget. 2017 Nov 20;8(63):106672-106684. doi: 10.18632/oncotarget.22508. eCollection 2017 Dec 5.
|
| 5 |
Exogenous DKK-3/REIC inhibits Wnt/-catenin signaling and cell proliferation in human kidney cancer KPK1.Oncol Lett. 2017 Nov;14(5):5638-5642. doi: 10.3892/ol.2017.6833. Epub 2017 Aug 28.
|
| 6 |
Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma.J Biol Chem. 2019 Mar 8;294(10):3760-3771. doi: 10.1074/jbc.RA118.004902. Epub 2019 Jan 7.
|
| 7 |
Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.Int J Cancer. 2004 Jan 10;108(2):243-50. doi: 10.1002/ijc.11456.
|
| 8 |
Ascorbate antagonizes nickel ion to regulate JMJD1A expression in kidney cancer cells.Acta Biochim Biophys Sin (Shanghai). 2012 Apr;44(4):330-8. doi: 10.1093/abbs/gms004. Epub 2012 Feb 7.
|
| 9 |
Calcitriol induces cell senescence of kidney cancer through JMJD3 mediated histone demethylation.Oncotarget. 2017 Oct 26;8(59):100187-100195. doi: 10.18632/oncotarget.22124. eCollection 2017 Nov 21.
|
| 10 |
KIF20B promotes the progression of clear cell renal cell carcinoma by stimulating cell proliferation.J Cell Physiol. 2019 Sep;234(9):16517-16525. doi: 10.1002/jcp.28322. Epub 2019 Feb 25.
|
| 11 |
Identification and characterization of angiogenesis targets through proteomic profiling of endothelial cells in human cancer tissues.PLoS One. 2013 Nov 13;8(11):e78885. doi: 10.1371/journal.pone.0078885. eCollection 2013.
|
| 12 |
RIP1-dependent reactive oxygen species production executes artesunate-induced cell death in renal carcinoma Caki cells.Mol Cell Biochem. 2017 Nov;435(1-2):15-24. doi: 10.1007/s11010-017-3052-7. Epub 2017 May 2.
|
| 13 |
Landscape of cancer diagnostic biomarkers from specifically expressed genes.Brief Bioinform. 2020 Dec 1;21(6):2175-2184. doi: 10.1093/bib/bbz131.
|
| 14 |
Research on circadian clock genes in common abdominal malignant tumors.Chronobiol Int. 2019 Jul;36(7):906-918. doi: 10.1080/07420528.2018.1477792. Epub 2019 Apr 24.
|
| 15 |
Hypoxia-Associated Factor (HAF) Mediates Neurofibromin Ubiquitination and Degradation Leading to Ras-ERK Pathway Activation in Hypoxia.Mol Cancer Res. 2019 May;17(5):1220-1232. doi: 10.1158/1541-7786.MCR-18-1080. Epub 2019 Jan 31.
|
| 16 |
High kinesin family member 11 expression predicts poor prognosis in patients with clear cell renal cell carcinoma.J Clin Pathol. 2019 May;72(5):354-362. doi: 10.1136/jclinpath-2018-205390. Epub 2019 Feb 28.
|
| 17 |
HOXA11-AS promotes the growth and invasion of renal cancer by sponging miR-146b-5p to upregulate MMP16 expression.J Cell Physiol. 2018 Dec;233(12):9611-9619. doi: 10.1002/jcp.26864. Epub 2018 Jun 28.
|
| 18 |
Elucidation of WW domain ligand binding specificities in the Hippo pathway reveals STXBP4 as YAP inhibitor.EMBO J. 2020 Jan 2;39(1):e102406. doi: 10.15252/embj.2019102406. Epub 2019 Nov 29.
|
| 19 |
LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling.Mol Carcinog. 2019 Feb;58(2):279-292. doi: 10.1002/mc.22926. Epub 2018 Oct 31.
|
| 20 |
Beta-2-glycoprotein-1 and alpha-1-antitrypsin as urinary markers of renal cancer in von Hippel-Lindau patients.Biomarkers. 2018 Mar;23(2):123-130. doi: 10.1080/1354750X.2016.1269132. Epub 2016 Dec 22.
|
| 21 |
Medication use and kidney cancer risk: Apopulation-based study.Eur J Cancer. 2017 Sep;83:203-210. doi: 10.1016/j.ejca.2017.07.001. Epub 2017 Jul 24.
|
| 22 |
An analysis of growth, differentiation and apoptosis genes with risk of renal cancer.PLoS One. 2009 Mar 24;4(3):e4895. doi: 10.1371/journal.pone.0004895.
|
| 23 |
Glutamine Deprivation Induces PD-L1 Expression via Activation of EGFR/ERK/c-Jun Signaling in Renal Cancer.Mol Cancer Res. 2020 Feb;18(2):324-339. doi: 10.1158/1541-7786.MCR-19-0517. Epub 2019 Oct 31.
|
| 24 |
Cadherin-6 gene expression in conventional renal cell carcinoma: a useful marker to detect circulating tumor cells.Anticancer Res. 2005 Jan-Feb;25(1A):377-81.
|
| 25 |
Reduced mRNA expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer.BMC Cancer. 2013 Apr 22;13:199. doi: 10.1186/1471-2407-13-199.
|
| 26 |
microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion.PLoS One. 2012;7(6):e37366. doi: 10.1371/journal.pone.0037366. Epub 2012 Jun 4.
|
| 27 |
Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas. Eur J Endocrinol. 2002 Dec;147(6):795-802.
|
| 28 |
Restoration of type 1 iodothyronine deiodinase expression in renal cancer cells downregulates oncoproteins and affects key metabolic pathways as well as anti-oxidative system.PLoS One. 2017 Dec 22;12(12):e0190179. doi: 10.1371/journal.pone.0190179. eCollection 2017.
|
| 29 |
Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways.Clin Cancer Res. 2009 Sep 15;15(18):5678-87. doi: 10.1158/1078-0432.CCR-09-0558.
|
| 30 |
Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.Oncogene. 2009 Sep 17;28(37):3274-85. doi: 10.1038/onc.2009.186. Epub 2009 Jul 6.
|
| 31 |
FKBP-12 exhibits an inhibitory activity on calcium oxalate crystal growth in vitro.J Korean Med Sci. 2002 Feb;17(1):41-8. doi: 10.3346/jkms.2002.17.1.41.
|
| 32 |
Overexpression of members of the AP-1 transcriptional factor family from an early stage of renal carcinogenesis and inhibition of cell growth by AP-1 gene antisense oligonucleotides in the Tsc2 gene mutant (Eker) rat model.Biochem Biophys Res Commun. 1997 Dec 8;241(1):24-30. doi: 10.1006/bbrc.1997.7731.
|
| 33 |
Integrative bioinformatics analysis reveals new prognostic biomarkers of clear cell renal cell carcinoma.Clin Chem. 2014 Oct;60(10):1314-26. doi: 10.1373/clinchem.2014.225854. Epub 2014 Aug 19.
|
| 34 |
Linking human genetics with molecular medicine: will hereditary renal cancer play a major role?.Cancer Biol Ther. 2004 May;3(5):441-6. doi: 10.4161/cbt.3.5.807. Epub 2004 May 18.
|
| 35 |
Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancer.J Clin Invest. 2015 Dec;125(12):4625-37. doi: 10.1172/JCI81040. Epub 2015 Nov 9.
|
| 36 |
Expression of adrenocorticotropin receptor gene in adrenocortical adenomas from patients with Cushing syndrome: possible contribution for the autonomous production of cortisol.Ann Surg. 2001 Jul;234(1):85-91. doi: 10.1097/00000658-200107000-00013.
|
| 37 |
The effect of a gene associated with retinoid-interferon-induced mortality 19 (GRIM-19) on STAT3-induced gene expression in renal carcinoma.J Biochem. 2018 Oct 1;164(4):285-294. doi: 10.1093/jb/mvy052.
|
| 38 |
Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth.Mol Cancer Ther. 2016 Sep;15(9):2119-29. doi: 10.1158/1535-7163.MCT-16-0197. Epub 2016 Jul 7.
|
| 39 |
High affinity binding of H3K14ac through collaboration of bromodomains 2, 4 and 5 is critical for the molecular and tumor suppressor functions of PBRM1.Mol Oncol. 2019 Apr;13(4):811-828. doi: 10.1002/1878-0261.12434. Epub 2019 Feb 2.
|
| 40 |
PGRMC1 Is a Novel Potential Tumor Biomarker of Human Renal Cell Carcinoma Based on Quantitative Proteomic and Integrative Biological Assessments. PLoS One. 2017 Jan 20;12(1):e0170453.
|
| 41 |
PinX1 represses renal cancer angiogenesis via the mir-125a-3p/VEGF signaling pathway.Angiogenesis. 2019 Nov;22(4):507-519. doi: 10.1007/s10456-019-09675-z. Epub 2019 Jun 28.
|
| 42 |
Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth.Oncotarget. 2014 Feb 28;5(4):1004-13. doi: 10.18632/oncotarget.1681.
|
| 43 |
PRKX, TTBK2 and RSK4 expression causes Sunitinib resistance in kidney carcinoma- and melanoma-cell lines.Int J Cancer. 2012 Jul 15;131(2):E45-55. doi: 10.1002/ijc.26486. Epub 2012 Feb 28.
|
| 44 |
Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer.J Urol. 2012 Dec;188(6):2063-71. doi: 10.1016/j.juro.2012.08.030. Epub 2012 Oct 18.
|
| 45 |
Molecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer.Clin Cancer Res. 2013 Jul 1;19(13):3345-52. doi: 10.1158/1078-0432.CCR-13-0304. Epub 2013 Apr 30.
|
| 46 |
Monocarboxylate transporter 1 and monocarboxylate transporter 4 in cancer-endothelial co-culturing microenvironments promote proliferation, migration, and invasion of renal cancer cells.Cancer Cell Int. 2019 Jun 28;19:170. doi: 10.1186/s12935-019-0889-8. eCollection 2019.
|
| 47 |
Urological cancer related to familial syndromes.Int Braz J Urol. 2017 Mar-Apr;43(2):192-201. doi: 10.1590/S1677-5538.IBJU.2016.0125.
|
| 48 |
Loss of der(3) in renal carcinoma cells of a patient with constitutional t(3;12).Hum Genet. 1988 Feb;78(2):148-50. doi: 10.1007/BF00278186.
|
| 49 |
Epigenetic regulation of thyroid hormone receptor beta in renal cancer.PLoS One. 2014 May 21;9(5):e97624. doi: 10.1371/journal.pone.0097624. eCollection 2014.
|
| 50 |
Expression analysis of MAC30 in human pancreatic cancer and tumors of the gastrointestinal tract.Histol Histopathol. 2004 Oct;19(4):1021-31. doi: 10.14670/HH-19.1021.
|
| 51 |
Data-driven Analysis of TRP Channels in Cancer: Linking Variation in Gene Expression to Clinical Significance.Cancer Genomics Proteomics. 2016 Jan-Feb;13(1):83-90.
|
| 52 |
Combining DNA Vaccine and AIM2 in H1 Nanoparticles Exert Anti-Renal Carcinoma Effects via Enhancing Tumor-Specific Multi-functional CD8(+) T-cell Responses.Mol Cancer Ther. 2019 Feb;18(2):323-334. doi: 10.1158/1535-7163.MCT-18-0832. Epub 2018 Nov 6.
|
| 53 |
YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells.Dev Cell. 2019 May 6;49(3):425-443.e9. doi: 10.1016/j.devcel.2019.04.014.
|
| 54 |
Coordinate expression of nuclear and mitochondrial genes involved in energy production in carcinoma and oncocytoma.Biochim Biophys Acta. 1996 Aug 23;1316(3):203-9. doi: 10.1016/0925-4439(96)00026-9.
|
| 55 |
Improved Total Synthesis of Tubulysins and Design, Synthesis, and Biological Evaluation of New Tubulysins with Highly Potent Cytotoxicities against Cancer Cells as Potential Payloads for Antibody-Drug Conjugates.J Am Chem Soc. 2018 Mar 14;140(10):3690-3711. doi: 10.1021/jacs.7b12692. Epub 2018 Jan 30.
|
| 56 |
miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancer. Oncogene. 2010 Sep 2;29(35):4914-24.
|
| 57 |
Efficient proximal gradient algorithm for inference of differential gene networks.BMC Bioinformatics. 2019 May 2;20(1):224. doi: 10.1186/s12859-019-2749-x.
|
| 58 |
Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer.Pharmacogenet Genomics. 2013 Dec;23(12):684-96. doi: 10.1097/FPC.0000000000000008.
|
| 59 |
The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.Carcinogenesis. 2011 Nov;32(11):1713-23. doi: 10.1093/carcin/bgr195. Epub 2011 Aug 30.
|
| 60 |
Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.BMC Cancer. 2010 Sep 3;10:477. doi: 10.1186/1471-2407-10-477.
|
| 61 |
Mutation screening of ACKR3 and COPS8 in kidney cancer cases from the CONFIRM study.Fam Cancer. 2017 Jul;16(3):411-416. doi: 10.1007/s10689-016-9961-x.
|
| 62 |
MAPK13 is preferentially expressed in gynecological cancer stem cells and has a role in the tumor-initiation.Biochem Biophys Res Commun. 2016 Apr 15;472(4):643-7. doi: 10.1016/j.bbrc.2016.03.004. Epub 2016 Mar 9.
|
| 63 |
Biological characteristics of renal cancer cells after CTP-mediated cancer suppressor gene NPRL2 protein treatment.Biol Chem. 2016 Nov 1;397(11):1163-1171. doi: 10.1515/hsz-2016-0143.
|
| 64 |
The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers.Oncotarget. 2017 Jan 17;8(3):4501-4519. doi: 10.18632/oncotarget.13885.
|
| 65 |
The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma.Am J Pathol. 2013 Apr;182(4):1163-70. doi: 10.1016/j.ajpath.2013.01.007. Epub 2013 Feb 12.
|
| 66 |
TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migration.Mol Oncol. 2018 Feb;12(2):166-179. doi: 10.1002/1878-0261.12149. Epub 2017 Dec 14.
|
| 67 |
TMEM106A inhibits cell proliferation, migration, and induces apoptosis of lung cancer cells.J Cell Biochem. 2019 May;120(5):7825-7833. doi: 10.1002/jcb.28057. Epub 2018 Nov 19.
|
| 68 |
Cross-cancer profiling of molecular alterations within the human autophagy interaction network.Autophagy. 2015;11(9):1668-87. doi: 10.1080/15548627.2015.1067362.
|
| 69 |
Anticancer activity of Schiff base-Poloxamer P85 combination against kidney cancer.Int Urol Nephrol. 2018 Feb;50(2):247-255. doi: 10.1007/s11255-017-1782-9. Epub 2017 Dec 29.
|
| 70 |
CDK5RAP3 Participates in Autophagy Regulation and Is Downregulated in Renal Cancer.Dis Markers. 2019 Apr 2;2019:6171782. doi: 10.1155/2019/6171782. eCollection 2019.
|
| 71 |
De novo design of thioredoxin reductase-targeted heterometallic titanocene-gold compounds of chlorambucil for mechanistic insights into renal cancer.Chem Commun (Camb). 2019 Dec 19;56(2):297-300. doi: 10.1039/c9cc07406f.
|
| 72 |
Blood pressure and kidney cancer risk: meta-analysis of prospective studies.J Hypertens. 2017 Jul;35(7):1333-1344. doi: 10.1097/HJH.0000000000001286.
|
| 73 |
Clear cell renal cell carcinoma with wild-type von Hippel-Lindau gene: a non-existent or new tumour entity?.Histopathology. 2019 Jan;74(1):60-67. doi: 10.1111/his.13749.
|
| 74 |
The Expression Patterns of FAM83H and PANX2 Are Associated With Shorter Survival of Clear Cell Renal Cell Carcinoma Patients.Front Oncol. 2019 Jan 22;9:14. doi: 10.3389/fonc.2019.00014. eCollection 2019.
|
| 75 |
The Diagnostic Value of FNDC5/Irisin in Renal Cell Cancer.Int Braz J Urol. 2018 Jul-Aug;44(4):734-739. doi: 10.1590/S1677-5538.IBJU.2017.0404.
|
| 76 |
Nutrient-induced FNIP degradation by SCF-TRCP regulates FLCN complex localization and promotes renal cancer progression.Oncotarget. 2017 Feb 7;8(6):9947-9960. doi: 10.18632/oncotarget.14221.
|
| 77 |
miR-19 promotes the proliferation of clear cell renal cell carcinoma by targeting the FRK-PTEN axis.Onco Targets Ther. 2019 Apr 10;12:2713-2727. doi: 10.2147/OTT.S199238. eCollection 2019.
|
| 78 |
Knockdown of GA-binding protein subunit 1 inhibits cell proliferation via p21 induction in renal cell carcinoma.Int J Oncol. 2018 Aug;53(2):886-894. doi: 10.3892/ijo.2018.4411. Epub 2018 May 17.
|
| 79 |
KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case-Control Study.Clin Cancer Res. 2018 Nov 15;24(22):5594-5601. doi: 10.1158/1078-0432.CCR-18-1496. Epub 2018 Jul 23.
|
| 80 |
A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma.Nat Commun. 2019 Mar 11;10(1):1152. doi: 10.1038/s41467-019-09116-x.
|
| 81 |
MTA2 as a Potential Biomarker and Its Involvement in Metastatic Progression of Human Renal Cancer by miR-133b Targeting MMP-9.Cancers (Basel). 2019 Nov 23;11(12):1851. doi: 10.3390/cancers11121851.
|
| 82 |
Knockdown of NSD2 Suppresses Renal Cell Carcinoma Metastasis by Inhibiting Epithelial-Mesenchymal Transition.Int J Med Sci. 2019 Sep 20;16(10):1404-1411. doi: 10.7150/ijms.36128. eCollection 2019.
|
| 83 |
Knockout of the Placenta Specific 8 Gene Affects the Proliferation and Migration of Human Embryonic Kidney 293T Cell.Cell Biochem Biophys. 2020 Mar;78(1):55-64. doi: 10.1007/s12013-019-00893-2. Epub 2019 Nov 6.
|
| 84 |
PLIN3 is up-regulated and correlates with poor prognosis in clear cell renal cell carcinoma.Urol Oncol. 2018 Jul;36(7):343.e9-343.e19. doi: 10.1016/j.urolonc.2018.04.006.
|
| 85 |
Prolonged survival of renal cancer patients is concomitant with a higher regucalcin gene expression in tumor tissues: Overexpression of regucalcin suppresses the growth of human renal cell carcinoma cells in vitro.Int J Oncol. 2019 Jan;54(1):188-198. doi: 10.3892/ijo.2018.4611. Epub 2018 Oct 30.
|
| 86 |
SGK2 promotes renal cancer progression via enhancing ERK 1/2 and AKT phosphorylation.Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2756-2767. doi: 10.26355/eurrev_201904_17549.
|
| 87 |
The ubiquitin ligase adaptor SPOP in cancer.FEBS J. 2019 Oct;286(20):3946-3958. doi: 10.1111/febs.15056. Epub 2019 Sep 18.
|
| 88 |
microRNA-mediated regulation of splicing factors SRSF1, SRSF2 and hnRNP A1 in context of their alternatively spliced 3'UTRs.Exp Cell Res. 2018 Feb 15;363(2):208-217. doi: 10.1016/j.yexcr.2018.01.009. Epub 2018 Jan 10.
|
| 89 |
Rho GTPase Activating Protein 24 (ARHGAP24) Silencing Promotes Lung Cancer Cell Migration and Invasion by Activating -Catenin Signaling.Med Sci Monit. 2019 Jan 1;25:21-31. doi: 10.12659/MSM.911503.
|
| 90 |
MiR-1208 Increases the Sensitivity to Cisplatin by Targeting TBCK in Renal Cancer Cells.Int J Mol Sci. 2019 Jul 19;20(14):3540. doi: 10.3390/ijms20143540.
|
| 91 |
Histological and molecular characterization of TFEB-rearranged renal cell carcinomas.Virchows Arch. 2019 May;474(5):625-631. doi: 10.1007/s00428-019-02526-8. Epub 2019 Jan 31.
|
| 92 |
Heterozygous Tsc2 (Tsc2+/-) mouse model to study induced renal cancer in response to ionizing radiation at low doses.Carcinogenesis. 2019 Jul 6;40(6):782-790. doi: 10.1093/carcin/bgy172.
|
| 93 |
Calcineurin inhibitor-induced and Ras-mediated overexpression of VEGF in renal cancer cells involves mTOR through the regulation of PRAS40.PLoS One. 2011;6(8):e23919. doi: 10.1371/journal.pone.0023919. Epub 2011 Aug 23.
|
| 94 |
Common variation at 1q24.1 (ALDH9A1) is a potential risk factor for renal cancer.PLoS One. 2015 Mar 31;10(3):e0122589. doi: 10.1371/journal.pone.0122589. eCollection 2015.
|
| 95 |
Genetic and Molecular Insights Into Genotype-Phenotype Relationships in Osteopathia Striata With Cranial Sclerosis (OSCS) Through the Analysis of Novel Mouse Wtx Mutant Alleles.J Bone Miner Res. 2018 May;33(5):875-887. doi: 10.1002/jbmr.3387. Epub 2018 Mar 1.
|
| 96 |
Melanotic Xp11 translocation renal cancer: a case with PSF-TFE3 gene fusion and up-regulation of melanogenetic transcripts.Am J Surg Pathol. 2009 Dec;33(12):1894-901. doi: 10.1097/PAS.0b013e3181ba7a5f.
|
| 97 |
Renal cancer and malformations in relatives of patients with Bardet-Biedl syndrome.Nephrol Dial Transplant. 2000 Dec;15(12):1977-85. doi: 10.1093/ndt/15.12.1977.
|
| 98 |
Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes.Tumour Biol. 2015 May;36(5):3197-207. doi: 10.1007/s13277-014-2190-8. Epub 2015 Apr 2.
|
| 99 |
Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma.Cancer Res. 2004 Mar 1;64(5):1632-8. doi: 10.1158/0008-5472.can-03-1687.
|
| 100 |
Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression.Br J Pharmacol. 2009 Nov;158(5):1405-12. doi: 10.1111/j.1476-5381.2009.00455.x. Epub 2009 Aug 13.
|
| 101 |
Expression and clinical significance of RCDG1 in renal cell carcinoma: a novel renal cancerassociated gene.Mol Med Rep. 2014 Sep;10(3):1583-9. doi: 10.3892/mmr.2014.2388. Epub 2014 Jul 16.
|
| 102 |
Expression and clinical significance of CacyBP/SIP in pancreatic cancer.Pancreatology. 2008;8(4-5):470-7. doi: 10.1159/000151774. Epub 2008 Sep 3.
|
| 103 |
CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway.Onco Targets Ther. 2018 Sep 25;11:6209-6216. doi: 10.2147/OTT.S172803. eCollection 2018.
|
| 104 |
Change in expression of cyclin G2 in kidney cancer cell and its significance.Tumour Biol. 2014 Apr;35(4):3177-83. doi: 10.1007/s13277-013-1415-6. Epub 2013 Nov 23.
|
| 105 |
VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migration.Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):1931-6. doi: 10.1073/pnas.1011777108. Epub 2011 Jan 13.
|
| 106 |
Differential expression of CHL1 gene during development of major human cancers.PLoS One. 2011 Mar 7;6(3):e15612. doi: 10.1371/journal.pone.0015612.
|
| 107 |
A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).Oncogene. 2003 Aug 14;22(34):5374-8. doi: 10.1038/sj.onc.1206686.
|
| 108 |
The expression of tumstatin is down-regulated in renal carcinoma.Mol Biol Rep. 2010 Jun;37(5):2273-7. doi: 10.1007/s11033-009-9718-9. Epub 2009 Aug 18.
|
| 109 |
Overexpression of COPS3 promotes clear cell renal cell carcinoma progression via regulation of Phospho-AKT(Thr308), Cyclin D1 and Caspase-3.Exp Cell Res. 2018 Apr 15;365(2):163-170. doi: 10.1016/j.yexcr.2018.02.025. Epub 2018 Feb 23.
|
| 110 |
Oncogenic cAMP responsive element binding protein 1 is overexpressed upon loss of tumor suppressive miR-10b-5p and miR-363-3p in renal cancer.Oncol Rep. 2016 Apr;35(4):1967-78. doi: 10.3892/or.2016.4579. Epub 2016 Jan 20.
|
| 111 |
The expression of Cullin1 is increased in renal cell carcinoma and promotes cancer cell proliferation, migration, and invasion.Tumour Biol. 2016 Sep;37(9):12823-12831. doi: 10.1007/s13277-016-5151-6. Epub 2016 Jul 23.
|
| 112 |
Dysregulated D-dopachrome tautomerase, a hypoxia-inducible factor-dependent gene, cooperates with macrophage migration inhibitory factor in renal tumorigenesis.J Biol Chem. 2014 Feb 7;289(6):3713-23. doi: 10.1074/jbc.M113.500694. Epub 2013 Dec 19.
|
| 113 |
Involvement of erbB4 and tumor marker genes in renal carcinoma regulatory network.Saudi J Biol Sci. 2017 Dec;24(8):1787-1791. doi: 10.1016/j.sjbs.2017.11.013. Epub 2017 Nov 10.
|
| 114 |
Selective effects of a fiber chimeric conditionally replicative adenovirus armed with hep27 gene on renal cancer cell.Cancer Biol Ther. 2016 Jun 2;17(6):664-73. doi: 10.1080/15384047.2016.1190485. Epub 2016 May 19.
|
| 115 |
Evidence of a tumour suppressor function for DLEC1 in human breast cancer.Anticancer Res. 2010 Apr;30(4):1079-82.
|
| 116 |
The Ets transcription factor ELF5 functions as a tumor suppressor in the kidney.Twin Res Hum Genet. 2011 Aug;14(4):316-22. doi: 10.1375/twin.14.4.316.
|
| 117 |
High expression of EPB41L5, an integral component of the Arf6-driven mesenchymal program, correlates with poor prognosis of squamous cell carcinoma of the tongue.Cell Commun Signal. 2016 Nov 21;14(1):28. doi: 10.1186/s12964-016-0151-0.
|
| 118 |
Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer.Exp Cell Res. 2007 Apr 15;313(7):1285-94. doi: 10.1016/j.yexcr.2007.01.021. Epub 2007 Feb 6.
|
| 119 |
Collecting duct carcinoma of the kidney: an immunohistochemical study of 11 cases.BMC Urol. 2004 Sep 9;4:11. doi: 10.1186/1471-2490-4-11.
|
| 120 |
The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources. Genet Med. 2022 Aug;24(8):1732-1742. doi: 10.1016/j.gim.2022.04.017. Epub 2022 May 4.
|
| 121 |
Birt-Hogg-Dub syndrome: from gene discovery to molecularly targeted therapies.Fam Cancer. 2013 Sep;12(3):357-64. doi: 10.1007/s10689-012-9574-y.
|
| 122 |
CircRNA ZNF609 functions as a competitive endogenous RNA to regulate FOXP4 expression by sponging miR-138-5p in renal carcinoma.J Cell Physiol. 2019 Jul;234(7):10646-10654. doi: 10.1002/jcp.27744. Epub 2018 Nov 27.
|
| 123 |
Role of secreted frizzled-related protein 3 in human renal cell carcinoma.Cancer Res. 2010 Mar 1;70(5):1896-905. doi: 10.1158/0008-5472.CAN-09-3549. Epub 2010 Feb 16.
|
| 124 |
Loss of expression of growth differentiation factor-9 (GDF9) in human kidney cancer and regulation of growth and migration of kidney cancer cells by GDF9.Anticancer Res. 2012 Oct;32(10):4375-83.
|
| 125 |
RGS-GAIP-interacting protein controls breast cancer progression.Mol Cancer Res. 2010 Dec;8(12):1591-600. doi: 10.1158/1541-7786.MCR-10-0209. Epub 2010 Oct 27.
|
| 126 |
Renal tumor-derived exosomes inhibit hepaCAM expression of renal carcinoma cells in a p-AKT-dependent manner.Neoplasma. 2014;61(4):416-23. doi: 10.4149/neo_2014_051.
|
| 127 |
HOX gene expression in normal and neoplastic human kidney.Int J Cancer. 1992 Jul 30;51(6):892-7. doi: 10.1002/ijc.2910510610.
|
| 128 |
Sensitization of renal carcinoma to radiation using alpha interferon (IFNA) gene transfection.Radiat Res. 1997 Nov;148(5):443-8.
|
| 129 |
Structural basis for renal cancer by the dynamics of pVHL-dependent JADE1 stabilization and -catenin regulation.Prog Biophys Mol Biol. 2019 Aug;145:65-77. doi: 10.1016/j.pbiomolbio.2018.12.005. Epub 2018 Dec 7.
|
| 130 |
Jam3 promotes migration and suppresses apoptosis of renal carcinoma cell lines.Int J Mol Med. 2018 Nov;42(5):2923-2929. doi: 10.3892/ijmm.2018.3854. Epub 2018 Sep 4.
|
| 131 |
Upregulation of the Kank1 gene-induced brain glioma apoptosis and blockade of the cell cycle in G0/G1 phase.Int J Oncol. 2014 Mar;44(3):797-804. doi: 10.3892/ijo.2014.2247. Epub 2014 Jan 8.
|
| 132 |
Expression of Kruppel-like factor 8 and Ki67 in lung adenocarcinoma and prognosis.Exp Ther Med. 2017 Aug;14(2):1351-1356. doi: 10.3892/etm.2017.4632. Epub 2017 Jun 20.
|
| 133 |
Involvement of ABC transporters in chemosensitivity of human renal cell carcinoma, and regulation of MRP2 expression by conjugated bilirubin.Anticancer Res. 2005 Jul-Aug;25(4):2729-35.
|
| 134 |
Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome. JAMA. 2010 Dec 22;304(24):2724-31. doi: 10.1001/jama.2010.1877.
|
| 135 |
MAML1 acts cooperatively with EGR1 to activate EGR1-regulated promoters: implications for nephrogenesis and the development of renal cancer.PLoS One. 2012;7(9):e46001. doi: 10.1371/journal.pone.0046001. Epub 2012 Sep 27.
|
| 136 |
Primary microcephaly gene MCPH1 shows a novel molecular biomarker of human renal carcinoma and is regulated by miR-27a.Int J Clin Exp Pathol. 2014 Jul 15;7(8):4895-903. eCollection 2014.
|
| 137 |
Exploring the hereditary background of renal cancer in Denmark.PLoS One. 2019 Apr 29;14(4):e0215725. doi: 10.1371/journal.pone.0215725. eCollection 2019.
|
| 138 |
Loss of MYBBP1A Induces Cancer Stem Cell Activity in Renal Cancer.Cancers (Basel). 2019 Feb 18;11(2):235. doi: 10.3390/cancers11020235.
|
| 139 |
L-MYC allelotype in renal cell carcinoma.Cancer Genet Cytogenet. 1996 May;88(1):66-8. doi: 10.1016/0165-4608(95)00275-8.
|
| 140 |
Inactivation of the von Hippel-Lindau tumour suppressor gene induces Neuromedin U expression in renal cancer cells.Mol Cancer. 2011 Jul 26;10:89. doi: 10.1186/1476-4598-10-89.
|
| 141 |
Genomic structure of human OKL38 gene and its differential expression in kidney carcinogenesis.J Biol Chem. 2004 Jan 2;279(1):743-54. doi: 10.1074/jbc.M308668200. Epub 2003 Oct 21.
|
| 142 |
P3H4 affects renal carcinoma through up-regulating miR-1/133a.Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5180-5186. doi: 10.26355/eurrev_201808_15714.
|
| 143 |
KIAA0101 is associated with human renal cell carcinoma proliferation and migration induced by erythropoietin.Oncotarget. 2016 Mar 22;7(12):13520-37. doi: 10.18632/oncotarget.5876.
|
| 144 |
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer.Cell Rep. 2018 Feb 27;22(9):2469-2481. doi: 10.1016/j.celrep.2018.02.028.
|
| 145 |
Bioplasmonic paper-based assay for perilipin-2 non-invasively detects renal cancer.Kidney Int. 2019 Dec;96(6):1417-1421. doi: 10.1016/j.kint.2019.08.020. Epub 2019 Sep 3.
|
| 146 |
PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors.Oncogene. 2001 Jan 11;20(2):178-87. doi: 10.1038/sj.onc.1204056.
|
| 147 |
Tumour-specific proline vulnerability uncovered by differential ribosome codon reading.Nature. 2016 Feb 25;530(7591):490-4. doi: 10.1038/nature16982. Epub 2016 Feb 15.
|
| 148 |
RNA-binding protein QKI-5 inhibits the proliferation of clear cell renal cell carcinoma via post-transcriptional stabilization of RASA1 mRNA.Cell Cycle. 2016 Nov 16;15(22):3094-3104. doi: 10.1080/15384101.2016.1235103. Epub 2016 Oct 21.
|
| 149 |
Gene expression and protein array studies of folliculin-regulated pathways.Anticancer Res. 2012 Nov;32(11):4663-70.
|
| 150 |
Rap GTPase Interactor: A Potential Marker for Cancer Prognosis Following Kidney Transplantation.Front Oncol. 2019 Aug 7;9:737. doi: 10.3389/fonc.2019.00737. eCollection 2019.
|
| 151 |
Prostaglandin E2 regulates renal cell carcinoma invasion through the EP4 receptor-Rap GTPase signal transduction pathway.J Biol Chem. 2011 Sep 30;286(39):33954-62. doi: 10.1074/jbc.M110.187344. Epub 2011 Aug 10.
|
| 152 |
High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.Eur J Surg Oncol. 2013 Jan;39(1):100-6. doi: 10.1016/j.ejso.2012.10.004. Epub 2012 Oct 24.
|
| 153 |
Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.Oncotarget. 2015 Jul 20;6(20):17895-910. doi: 10.18632/oncotarget.4963.
|
| 154 |
Parathyroid hormone-related protein. Evidence for secretion of a novel mid-region fragment by three different cell types.J Biol Chem. 1992 Sep 5;267(25):18236-43.
|
| 155 |
Knockdown of ribosomal protein S15A inhibits human kidney cancer cell growth invitro and invivo.Mol Med Rep. 2019 Feb;19(2):1117-1127. doi: 10.3892/mmr.2018.9751. Epub 2018 Dec 12.
|
| 156 |
Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma.Hum Pathol. 2015 Dec;46(12):1951-5. doi: 10.1016/j.humpath.2015.07.027. Epub 2015 Sep 5.
|
| 157 |
Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3.Endocr Relat Cancer. 2012 May 3;19(3):283-90. doi: 10.1530/ERC-11-0324. Print 2012 Jun.
|
| 158 |
Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer.Clin Cancer Res. 2017 Jul 1;23(13):3428-3441. doi: 10.1158/1078-0432.CCR-16-2020. Epub 2016 Nov 22.
|
| 159 |
p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1).Biochem J. 2004 May 15;380(Pt 1):289-95. doi: 10.1042/BJ20031299.
|
| 160 |
Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors.J Exp Clin Cancer Res. 2010 Nov 16;29(1):147. doi: 10.1186/1756-9966-29-147.
|
| 161 |
Cepharanthine Enhances TRAIL-Mediated Apoptosis Through STAMBPL1-Mediated Downregulation of Survivin Expression in Renal Carcinoma Cells.Int J Mol Sci. 2018 Oct 22;19(10):3280. doi: 10.3390/ijms19103280.
|
| 162 |
A Hypoxia-Inducible HIF1-GAL3ST1-Sulfatide Axis Enhances ccRCC Immune Evasion via Increased Tumor Cell-Platelet Binding.Mol Cancer Res. 2019 Nov;17(11):2306-2317. doi: 10.1158/1541-7786.MCR-19-0461. Epub 2019 Aug 19.
|
| 163 |
Renal cancer: molecular mechanisms and newer therapeutic options.Curr Opin Nephrol Hypertens. 2002 Jan;11(1):37-42. doi: 10.1097/00041552-200201000-00006.
|
| 164 |
Fluorescence in situ hybridization analysis on cytologic smears: An accurate and efficient method in the diagnosis of melanotic Xp11 translocation renal cancer.Diagn Cytopathol. 2018 Sep;46(9):786-789. doi: 10.1002/dc.23961. Epub 2018 May 3.
|
| 165 |
Characterization of the role of TMEM45A in cancer cell sensitivity to cisplatin.Cell Death Dis. 2019 Dec 4;10(12):919. doi: 10.1038/s41419-019-2088-x.
|
| 166 |
Loss of TOP3B leads to increased R-loop formation and genome instability.Open Biol. 2019 Dec;9(12):190222. doi: 10.1098/rsob.190222. Epub 2019 Dec 4.
|
| 167 |
The significance of TRIP11 and T3 signalling pathway in renal cancer progression and survival of patients.Endokrynol Pol. 2017;68(6):631-641. doi: 10.5603/EP.a2017.0052. Epub 2017 Oct 12.
|
| 168 |
TRC8 suppresses tumorigenesis through targeting heme oxygenase-1 for ubiquitination and degradation.Oncogene. 2013 May 2;32(18):2325-34. doi: 10.1038/onc.2012.244. Epub 2012 Jun 11.
|
| 169 |
Design, synthesis and evaluation of novel sulfonamides as potential anticancer agents.Comput Biol Chem. 2018 Jun;74:294-303. doi: 10.1016/j.compbiolchem.2018.04.006. Epub 2018 Apr 10.
|
|
|
|
|
|
|
